SCHEMBL7302748

SCHEMBL7302748

CC(C)COc1ccc(NC(=O)c2ccc3c(c2)CCCC3)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.58
▸ RAB9A P51151 6/20 0.57
▸ NPC1 O15118 5/20 0.57
▸ SMN1; SMN2 Q16637 5/20 0.57
▸ KMT2A Q03164 4/20 0.57
▸ LMNA P02545 1/20 0.57
▸ POLB P06746 2/20 0.56
▸ MEN1 O00255 2/20 0.55
▸ RXFP1 Q9HBX9 1/20 0.55
▸ NR1H4 Q96RI1 2/20 0.55
▸ TDP1 Q9NUW8 1/20 0.52
▸ TP53 P04637 3/20 0.52
▸ ALDH1A1 P00352 2/20 0.50
▸ TRPV1 Q8NER1 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ NFKB2 Q00653 1/20 0.50
▸ RELA Q04206 1/20 0.50
▸ GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7300048 0.82 RAB9A (0.74) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7344722 0.79 MAPT (0.58) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7306324 0.78 NPC1 (0.78) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL12523461 0.75 KMT2A (0.67) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7301810 0.75 KMT2A (0.67) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL3366233 0.75 NPC1 (0.72) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL20932779 0.74 ALDH1A1 (0.59) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL5181351 0.74 MAPT (0.64) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL23090417 0.74 DHODH (0.62) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL24170919 0.73 ALDH1A1 (0.58) MAPTRAB9ANPC1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0666250-B1 Derivatives of N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide having neuroprotective and anti-ischemic properties, their preparation and their use, in therapy SYNTHELABO (FR) 1998-02-11 — — EP disclosed
US-5663183-A CEREBRAL DISORDERS SYNTHELABO (FR) 1997-09-02 — — US disclosed
US-5550162-A TREATMENT AND PREVENTION OF CEREBRAL DISORDERS SYNTHELABO (FR) 1996-08-27 — — US disclosed
EP-0666250-A1 Derivatives of N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide having neuroprotective and anti-ischemic properties, their preparation and their use, in therapy SYNTHELABO (FR) 1995-08-09 — — EP disclosed
Send feedback